Literature DB >> 1873793

CAncer Rehabilitation Evaluation System--short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument.

C A Schag1, P A Ganz, R L Heinrich.   

Abstract

The CAncer Rehabilitation Evaluation System (CARES) (CARES Consultants, Santa Monica, CA) a rehabilitation and quality of life instrument with well-documented reliability and validity, has been shortened. This report describes the development and psychometric properties of the new instrument, the CAncer Rehabilitation Evaluation System--Short Form (CARES-SF). The data from four existing samples of cancer patients demonstrate that the CARES-SF is highly related to the CARES (r = 0.98), has excellent test-retest reliability (86% agreement), concurrent validity with related measures, and acceptable internal consistency of summary scales (alpha = 0.85 to 0.61). In a new sample of breast cancer patients evaluated at three points in time (1 month, 7 months, and 13 months after diagnosis) the instrument appears to be sensitive to change and is highly related to the Functional Living Index--Cancer (FLIC), an existing quality of life instrument. The authors conclude that the CARES-SF has excellent potential as a quality of life instrument for use in clinical trials.

Entities:  

Mesh:

Year:  1991        PMID: 1873793     DOI: 10.1002/1097-0142(19910915)68:6<1406::aid-cncr2820680638>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  87 in total

1.  Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy.

Authors:  B Conner-Spady; C Cumming; J M Nabholtz; P Jacobs; D Stewart
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

Review 2.  Measuring the effect of cancer on health-related quality of life.

Authors:  D Osoba
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

3.  Occurrences and sources of Differential Item Functioning (DIF) in patient-reported outcome measures: Description of DIF methods, and review of measures of depression, quality of life and general health.

Authors:  Jeanne A Teresi; Mildred Ramirez; Jin-Shei Lai; Stephanie Silver
Journal:  Psychol Sci Q       Date:  2008

4.  Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma.

Authors:  D Osoba; N K Aaronson; M Muller; K Sneeuw; M A Hsu; W K Yung; M Brada; E Newlands
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

5.  Development and evaluation of an instrument to assess social difficulties in routine oncology practice.

Authors:  E P Wright; M Kiely; C Johnston; A B Smith; A Cull; P J Selby
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

6.  The feasibility, reliability and validity of the McGill Quality of Life Questionnaire-Cardiff Short Form (MQOL-CSF) in palliative care population.

Authors:  Pei Lin Lua; Sam Salek; Ilora Finlay; Chris Lloyd-Richards
Journal:  Qual Life Res       Date:  2005-09       Impact factor: 4.147

7.  Individual differences in well-being in older breast cancer survivors.

Authors:  Elizabeth A Perkins; Brent J Small; Lodovico Balducci; Martine Extermann; Claire Robb; William E Haley
Journal:  Crit Rev Oncol Hematol       Date:  2007-01-19       Impact factor: 6.312

8.  A comparison of three sets of criteria for determining the presence of differential item functioning using ordinal logistic regression.

Authors:  Paul K Crane; Laura E Gibbons; Katja Ocepek-Welikson; Karon Cook; David Cella; Kaavya Narasimhalu; Ron D Hays; Jeanne A Teresi
Journal:  Qual Life Res       Date:  2007-06-07       Impact factor: 4.147

9.  The CARES: a generic measure of health-related quality of life for patients with cancer.

Authors:  P A Ganz; C A Schag; J J Lee; M S Sim
Journal:  Qual Life Res       Date:  1992-02       Impact factor: 4.147

10.  Development and validation of the Short-Form Survivor Unmet Needs Survey (SF-SUNS).

Authors:  H Sharon Campbell; Alix E Hall; Rob W Sanson-Fisher; Daniel Barker; Donna Turner; Jill Taylor-Brown
Journal:  Support Care Cancer       Date:  2013-11-29       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.